Effect of a novel PACAP-27 analogue on muscarinic airway responsiveness in guinea-pigs in vivo

European Respiratory Journal

Volumn 12, Issue 5, 1998, Pages 1062-1066

  Okazawa, A ^a   Cui, Z H ^a   Lotvall J ^a   Yoshihara, S ^b   Skoogh, B E ^a   Kashimoto, K ^c   Linden A ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b DOKKYO MEDICAL UNIVERSITY   (Japan)

^c Itoham Central Research Institute   (Japan)

Author keywords

Acetylcholine; Airway responsiveness; Bronchodilator; Lung resistance; Pituitary adenylate cyclase activating peptide; Salbutamol

Indexed keywords

ACETYLCHOLINE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE 27; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE DERIVATIVE; SALBUTAMOL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREATHING MUSCLE; BRONCHODILATATION; BRONCHUS REACTIVITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; GUINEA PIG; INTRATRACHEAL DRUG ADMINISTRATION; LUNG RESISTANCE; MALE; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE RELAXATION;

EID: 0031789216     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.98.12051062     Document Type: Article

References (16)

1. Miyata A, Arimura A, Dahl RR, et al. Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem Biophys Res Commun 1989; 164: 565-574.
2. Miyata A, Jiang L, Dahl RD, et al. Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP38). Biochem Biophys Res Commun 1990; 170: 643-648.
3. Cardell LO, Uddman R, Luts A, Sundler F. Pituitary adenylate cyclase activating peptide (PACAP) in guinea-pig lung: distribution and dilatory effects. Regul Pept 1991; 36: 379-390.
4. Uddman R, Luts A, Arimura A, Sundler F. Pituitary adenylate cyclase-activating peptide (PACAP), a new vasoactive intestinal peptide (VIP)-like peptide in the respiratory tract. Cell Tissue Res 1991; 265: 197-201.
5. Luts A, Uddman R, Alm P, Basterra J, Sundler F. Peptide-containing nerve fibers in human airways: distribution and coexistence pattern. Int Arch Allergy Immunol 1993; 101: 52-60.
6. Araki N, Takagi K. Relaxant effect of pituitary adenylate cyclase-activating polypeptide on guinea-pig tracheal smooth muscle. Eur J Pharmacol 1992; 216: 113-117.
7. --ATPase in airway smooth muscle relaxation by vasoactive intestinal peptide and pituitary adenylate cyclase activating peptide. Res Commun Chem Pathol Pharmacol 1993; 79: 11-22.
8. Lindén A, Yoshihara S, Chan B, Nadel JA. Inhibition of bronchoconstriction by pituitary adenylate cyclase activating polypeptide (PACAP 1-27) in guinea-pigs in vivo. Br J Pharmacol 1995; 115: 913-916.
9. Lindén A, Cardell LO, Yoshihara S, Stjärne P, Nadel JA. PACAP 1-38 as an inhaled bronchodilator in guinea pigs in vivo. Peptides 1998; 19: 93-98.
10. Yoshihara S, Lindén A, Kashimoto K, Nagano Y, Ichimura T, Nadel JA. Long lasting smooth muscle relaxation by a novel PACAP analogue in guinea-pig and primate airways in vitro. Br J Pharmacol 1997; 121: 1730-1734.
11. von Neergaard K, Wirz K. Die Messung der Strömungswiderstände in den Atemwegem des Menschen, insbesondere bei Asthma und Emphysem. Z Klin Med 1927; 105: 51-82
12. 2 or leukotrienes. Br J Pharmacol 1993; 110: 657-664.
13. Kashimoto K, Nagano Y, Suitani Y, et al. Structure-activity relationship studies of PACAP-27 and VIP analogues. Ann NY Acad Sci 1996; 805: 505-510.
14. Nandha KA, Benito-Orfila MA, Smith DM, Ghatei MA, Bloom SR. Action of pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide on the rat vascular system: effects on blood pressure and receptor binding. J Endocrinol 1991; 129: 69-73.
15. Ishizuka Y, Kashimoto K, Mochizuki T, Sato K, Ohshima K, Yanaihara N. Cardiovascular and respiratory actions of pituitary adenylate cyclase-activating polypeptides. Regul Pept 1992; 40: 29-39.
16. Arakawa H, Lötvall J, Kawikova I, et al. Airway allergy to trimellitic anhydride in guinea pigs: different time courses of IgG1 titer and airway responses to allergen challenge. J Allergy Clin Immunol 1993; 92: 425-434.